VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

171 hedge funds and large institutions have $818M invested in Verve Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 50 increasing their positions, 67 reducing their positions, and 57 closing their positions.

Holders
171
Holders Change
-21
Holders Change %
-10.94%
% of All Funds
2.3%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
40
Increased
50
Reduced
67
Closed
57
Calls
$3.93M
Puts
$41M
Net Calls
-$37M
Net Calls Change
-$37.8M

Top Buyers

1
PCM
1
Pentwater Capital Management
Florida
$75.5M
2
AAM
2
Alpine Associates Management
Florida
$30.8M
3
FCM
3
Farallon Capital Management
California
$40.6M
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$19.6M
5
UBS Group
5
UBS Group
Switzerland
$21M

Top Sellers

1
BI
1
BVF Inc
California
$0
2
SSA
2
Schonfeld Strategic Advisors
New York
$1.98M
3
Millennium Management
3
Millennium Management
New York
$1.55M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$90K
5
NHAS
5
Novo Holdings A/S
Denmark
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PA
226
Parallel Advisors
California
– – -23 Closed
WCM
227
WealthTrak Capital Management
Virginia
– – -20 Closed
DP
228
Diadema Partners
New Jersey
– – – –
JFG
229
Jefferies Financial Group
New York
– – – –
C
230
Covestor
United Kingdom
$0 14 – –
PAP
231
Persistent Asset Partners
Hong Kong
– – – –
6 7 8 9
10